|
시장보고서
상품코드
2055162
랩온어칩(Lab-on-a-chip) 시장 : 제품 및 서비스별, 기술별, 용도별, 최종사용자별, 지역별Lab on Chip Market, By Product and Service, By Technology (Microarrays, Microfluidics, Tissue Biochip, and Others ), By Application, By End User, By Geography |
||||||
랩온어칩 시장은 2026년에 79억 3,000만 달러로 추정되며, 2033년까지 154억 6,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 10.0%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 79억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.00% | 2033년 시장 규모 예측 : | 154억 6,000만 달러 |
세계 랩온어칩(Lab-on-a-chip) 시장은 마이크로플루이딕스공학, 생명공학, 분석화학의 획기적인 융합을 상징하며, 의료, 제약, 생명과학 각 분야의 진단 및 연구 기법을 근본적으로 혁신하고 있습니다.
마이크로유체 장치로도 알려진 랩온어칩(LOC) 기술은 불과 수 mm에서 수 센티미터 크기의 단일 칩 위에 여러 실험실 기능을 통합하여, 전례 없는 정밀도와 효율성으로 생물학적 시료의 소형화된 분석을 가능하게 합니다. 이러한 첨단 장치는 마이크로채널, 펌프, 믹서, 검출기를 활용하여 제어된 미세 환경 내에서 시료 전처리, 반응, 분리, 검출과 같은 복잡한 생화학적 과정을 수행합니다.
시료량 감소, 시약 소비 최소화, 분석 시간 단축, 그리고 높은 처리 능력을 실현하는 이 기술은 현대의 현장 진단 및 맞춤형 의료 분야의 기반 기술로 자리매김하고 있습니다. 전 세계 의료 시스템에서 신속하고 정확하며 비용 효율적인 진단 솔루션이 점점 더 중요시되는 가운데, 특히 코로나19 팬데믹을 계기로 분산형 검사 역량의 필요성이 부각됨에 따라, 랩온어칩 플랫폼은 차세대 의료기기의 핵심 기반으로서 부상하고 있습니다. 이러한 기술들은 감염병 검출 및 암 바이오마커 분석부터 환경 모니터링 및 신약 개발 과정에 이르기까지 폭넓은 용도를 뒷받침하고 있습니다.
시장 역학
세계 랩온어칩 시장은 여러 산업에 걸친 혁신의 가능성을 뒷받침하는 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 전 세계적으로 만성 질환과 감염병이 확산되고 고령화 사회가 진행됨에 따라, 랩온어칩 기술이 소형화, 휴대성, 그리고 비용 대비 높은 검사 효율성을 통해 독자적으로 제공하는 신속하고 정확한 진단 솔루션에 대한 수요가 크게 증가하고 있습니다.
의료의 디지털화 추세와 맞춤형 의료로의 전환 또한 시장 성장을 더욱 가속화하고 있습니다. LOC 장치는 맞춤형 치료 접근법에 필수적인 정밀한 바이오마커 검출, 유전자 분석 및 약물 스크리닝의 적용을 가능하게 하기 때문입니다. 게다가 신흥국의 의료비 증가와 더불어, 현장 진단(Point-of-Care) 검사 인프라 구축을 추진하는 정부의 이니셔티브이 맞물리면서 시장 확대의 큰 기회가 생겨나고 있습니다.
그러나 시장에는 높은 초기 개발 비용, 복잡한 규제 승인 절차, 기기의 표준화 및 제조 확장성과 관련된 기술적 과제 등 뚜렷한 제약 요인이 존재합니다. 마이크로플루이딕스 장치의 제조는 고도의 기술을 요하기 때문에 전문적인 노하우와 첨단 제조 설비가 필요하며, 이로 인해 중소기업 시장 진입이 제한될 가능성이 있어 보급에 걸림돌이 될 우려가 있습니다.
또한, 기기의 신뢰성에 대한 우려, 교차 오염의 위험, 그리고 복잡한 시스템을 운영하기 위한 숙련된 인력의 필요성은 자원이 제한된 환경에서 시장 침투를 저해할 수 있습니다. 이러한 과제가 있음에도 불구하고, 나노기술의 통합이 진전되고, 데이터 분석 강화를 위한 인공지능 도입, 그리고 환경 모니터링, 식품 안전 검사, 제약 연구 분야에서의 활용이 확대됨에 따라 큰 기회가 창출되고 있습니다. 이로 인해 랩온어칩 시장은 지속적인 성장과 기술적 진화의 궤도에 올랐습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 랩온어칩(Lab-on-a-Chip) 시장의 주요 기업 프로파일을 작성하였습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 '랩 온 칩(Lab-on-a-Chip)' 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 애널리스트를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 랩온어칩 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 랩온어칩 시장 : 제품 및 서비스별, 2021년-2033년
제5장 세계의 랩온어칩 시장 : 기술별, 2021년-2033년
제6장 세계의 랩온어칩 시장 : 용도별, 2021년-2033년
제7장 세계의 랩온어칩 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 랩온어칩 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
LSH 26.06.22Lab on Chip Market is estimated to be valued at USD 7.93 Bn in 2026 and is expected to reach USD 15.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.93 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.00% | 2033 Value Projection: | USD 15.46 Bn |
The global lab on chip market represents a revolutionary convergence of microfluidics, biotechnology, and analytical chemistry, fundamentally transforming diagnostic and research methodologies across healthcare, pharmaceutical, and life sciences sectors.
Lab-on-chip (LOC) technology, also known as microfluidic devices, integrates multiple laboratory functions onto a single chip measuring just millimeters to a few centimeters in size, enabling miniaturized analysis of biological samples with unprecedented precision and efficiency. These sophisticated devices leverage microchannels, pumps, mixers, and detectors to perform complex biochemical processes including sample preparation, reaction, separation, and detection within a controlled microenvironment.
The technology's ability to reduce sample volumes, minimize reagent consumption, accelerate analysis time, and deliver high-throughput capabilities has positioned it as a cornerstone of modern point-of-care diagnostics and personalized medicine initiatives. As healthcare systems worldwide increasingly prioritize rapid, accurate, and cost-effective diagnostic solutions, particularly following the COVID-19 pandemic's emphasis on decentralized testing capabilities, lab-on-chip platforms have emerged as critical enablers of next-generation medical devices, supporting applications ranging from infectious disease detection and cancer biomarker analysis to environmental monitoring and drug discovery processes.
Market Dynamics
The global lab on chip market is propelled by several compelling drivers that underscore its transformative potential across multiple industries. The increasing prevalence of chronic diseases, infectious diseases, and the growing aging population worldwide creates substantial demand for rapid, accurate diagnostic solutions that lab-on-chip technology uniquely provides through its miniaturized, portable, and cost-effective testing capabilities.
Healthcare digitization trends and the shift toward personalized medicine further accelerate market growth, as LOC devices enable precise biomarker detection, genetic analysis, and drug screening applications essential for tailored therapeutic approaches. Additionally, rising healthcare expenditure in emerging economies, coupled with government initiatives promoting point-of-care testing infrastructure, creates significant market expansion opportunities.
However, the market faces notable restraints including high initial development costs, complex regulatory approval processes, and technical challenges related to device standardization and manufacturing scalability. The sophisticated nature of microfluidic device fabrication requires specialized expertise and advanced manufacturing facilities, potentially limiting market accessibility for smaller companies and creating barriers to widespread adoption.
Furthermore, concerns regarding device reliability, cross-contamination risks, and the need for skilled personnel to operate complex systems may hinder market penetration in resource-limited settings. Despite these challenges, substantial opportunities emerge from advancing nanotechnology integration, artificial intelligence incorporation for enhanced data analysis, and expanding applications in environmental monitoring, food safety testing, and pharmaceutical research, positioning the lab-on-chip market for sustained growth and technological evolution.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lab on chip market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, BioMerieux, Danaher Corporation, PerkinElmer, Illumina, QIAGEN, Merck Group, Roche Diagnostics, Becton Dickinson (BD), Tecan Group, Luminex Corporation, and Fluidigm Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lab on chip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lab on chip market
Market Segmentation
- Product and Service Insights (Revenue, USD Bn, 2021 - 2033)
- Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
- Software and Services (data analytics, remote monitoring, workflow automation, etc.)
- Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Microarrays
- DNA Microarrays (Gene Chips)
- Protein Microarrays
- Antibody Microarrays
- Microfluidics
- Continuous-flow Microfluidics
- Droplet-based Microfluidics (Digital Microfluidics)
- Optofluidics
- Acoustofluidics
- Tissue Biochip
- 2D Cell Culture Chips
- 3D Cell Culture and Organ-on-a-Chip
- Others (emerging or hybrid technologies)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Genomics
- Proteomics
- Diagnostics
- Drug Discovery
- Point-of-Care Testing
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Biotechnology and Pharmaceutical Companies
- Diagnostic Centers
- Contract Research Organizations (CROs)
- Forensic Laboratories
- Home Care Settings
- Others (Academic and Research Institutes)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Agilent Technologies
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- BioMerieux
- Danaher Corporation
- PerkinElmer
- Illumina
- QIAGEN
- Merck Group
- Roche Diagnostics
- Becton Dickinson (BD)
- Tecan Group
- Luminex Corporation
- Fluidigm Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Lab on Chip Market, By Product and Service
- Global Lab on Chip Market, By Technology
- Global Lab on Chip Market, By Application
- Global Lab on Chip Market, By End User
- Global Lab on Chip Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Lab on Chip Market, By Product and Service, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services (data analytics, remote monitoring, workflow automation, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Lab on Chip Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microarrays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- DNA Microarrays (Gene Chips)
- Protein Microarrays
- Antibody Microarrays
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Continuous-flow Microfluidics
- Droplet-based Microfluidics (Digital Microfluidics)
- Optofluidics
- Acoustofluidics
- Tissue Biochip
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 2D Cell Culture Chips
- 3D Cell Culture and Organ-on-a-Chip
- Others (emerging or hybrid technologies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Lab on Chip Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Lab on Chip Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Forensic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Academic and Research Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Lab on Chip Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tecan Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
